This research demonstrates efficient synthesis of fullerene composites, enhancing stability and efficiency in solar cells, indicating significant commercial potential.
The high cost and detrimental self-aggregation of conventional single-component fullerenes such as C60 and PCBM constitute a major obstacle to the commercialization of inverted perovskite solar cells (IPSCs). We report a kilogram-scale, one-pot synthesis of a multi-component fullerene composite (FC), comprising C60, a bis((3-methyloxetan-3-yl)methyl) malonate-C60 mono-adduct (BCM), and its bis-adduct (BCB). FC is obtained in 96% yields without complex column chromatography, significantly reducing production costs. Upon thermal annealing, BCM and BCB undergo cross-linking to form a robust encapsulation network that homogeneously incorporates C60, enhancing film stability and electron mobility. IPSCs incorporating cross-linked fullerene composite (CFC) demonstrate an impressive efficiency of 26.55%, surpassing that of PCBM-based devices (24.82%). Additionally, CFC-based devices maintain 96.0% and 95.1% of their initial efficiency after 1000 hours under ISOS-L-1 and ISOS-D-2 protocols, respectively. Notably, CFC demonstrates excellent performance across a range of device configurations, including wide-bandgap (1.68 eV and 1.77 eV) cells, large-area devices (1 cm2), and mini-modules (14.4 cm2). High cost and aggregation of single-component fullerenes hinder inverted perovskite solar cell development. The authors synthesize a fullerene composite in high yield that cross-links during annealing, improving stability and efficiency while maintaining performance in various device formats.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: